We retrospectively investigated the incidence and prognosis of and risk factors for cerebrovascular events in 1,064 patients with chronic uremia who received maintenance hemodialysis (HD) for more than 3 months during 24 years in our dialysis units in Miyazaki, Japan. Cerebrovascular events developed in 98 patients (9.2%). The confirmed incidences of cerebral hemorrhage (CH) and infarction were 8.7 and 3.7 per 1,000 patient-years, respectively. Of the 56 patients with CH, 40 (71.4%) died within 3 months of the onset of CH. Ganglio-thalamic lesion was observed in 32 (80.0%) of 40 patients with CH confirmed by a brain computed tomography. The incidence of polycystic kidney disease was higher in the CH group than in the overall HD population (12.5% v 3.9%, P < 0.01). Of the 13 patients with diabetes mellitus and nephrosclerosis, nine (69.2%) developed CH within 36 months of the initiation of HD; 11 (78.6%) of 14 patients with chronic glomerulonephritis developed CH after 36 months. CH developed in six patients (15.0%) within 6 hours of a previous HD session. We compared laboratory values, the supine blood pressure, and electrocardiographic (ECG) findings in 35 patients with CH and a control group (66 patients) matched in age, sex,...Continue Reading
Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients
High prevalence of intracranial artery calcification in stroke patients with CKD: a retrospective study.
Brachial-ankle pulse wave velocity predicts silent cerebrovascular diseases in patients with end-stage renal diseases
One-year mortality associations in hemodialysis patients after traumatic brain injury--an eight-year population-based study
Intubation without premedication may worsen outcome for unconsciousness patients with intracranial hemorrhage
Relation between intracranial artery calcifications and aortic atherosclerosis in ischemic stroke patients.
Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients
Superior outcome of nafamostat mesilate as an anticoagulant in patients undergoing maintenance hemodialysis with intracerebral hemorrhage
Long-term morbidity and mortality of carotid endarterectomy in patients with end-stage renal disease receiving hemodialysis
The intersection of risk and benefit: is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis?
Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS
Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy
Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis
Prognostic factors of spontaneous intracerebral haemorrhage in haemodialysis patients and predictors of 30-day mortality
The association between blood pressure and mortality in ESRD-not different from the general population?
Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis
Haemodialysis and the risk of stroke: A population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease
Atrial fibrillation and warfarin use in haemodialysis patients: an individualized holistic approach is important in stroke prevention
Hyperhomocysteinemia is a significant risk factor for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis
Effect of one-shot intravenous 0.42 mega unit urokinase therapy in patients with acute ischemic stroke
Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.